Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Oncor's Sunrise Amplification Detection System presented

April 23, 1997

Genetronics develops electroporation therapy drug delivery system

April 23, 1997

AntiCancer receives grant for development of mouse cancer model

April 21, 1997

Ribozyme and Schering AG to collaborate on target validation and therapeutic development

April 21, 1997

Estrogen receptor structure elucidated

April 18, 1997

Vion's TAPET technology demonstrates potential to target and inhibit tumor growth

April 17, 1997

Oxford Molecular Group launches drug discovery software tool

April 17, 1997

Matrix issued U.S. patent for drug delivery technology; preclinical data presented

April 16, 1997

Verigen and Tufts to develop transgenic pigs to produce humanized antibodies

April 10, 1997

Penederm and SmithKline Beecham announce OTC collaboration

April 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...